Mouse Anti-ACE Recombinant Antibody (V2-179257) (CBMAB-A0529-YC)

Name: Mouse Anti-ACE Recombinant Antibody (V2-179257)
SKU: CBMAB-A0529-YC
Rating: 5 (1 reviews)

See all ACE antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

V2-179257

Application

ELISA, ICC, IHC, IP, WB

Immunogen

Angiotensin-converting enzyme from human lung

Specificity

Human, Cat, Hamster, Monkey, Rat

Antibody Isotype

IgG1

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Application	Note
WB	1:100
ELISA	1:1,000
IF(ICC)	1:100
IHC	1:1,000
IP	1:1,000-1:10,000

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Liquid in PBS, pH 7.4, 150 mM sodium chloride, 0.05% sodium azide

Buffer

PBS, pH7.4

Preservative

0.05% sodium azide

Concentration

Batch dependent

Storage

Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

More Infomation

Target

Full Name

Angiotensin I Converting Enzyme

Introduction

ACE is an enzyme involved in catalyzing the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte bal

Entrez Gene ID

Human	1636
Cat	101094061
Rat	24310
Hamster	103158533
Monkey	100428661

UniProt ID

Human	P12821
Cat	A0A2I2UTZ7
Rat	P47820
Hamster	Q50JE5
Monkey	Q9GLN7

Alternative Names

Angiotensin I Converting Enzyme; Angiotensin I Converting Enzyme (Peptidyl-Dipeptidase A) 1; Dipeptidyl Carboxypeptidase I; CD143 Antigen; Kininase II; DCP1; DCP; Angiotensin Converting Enzyme, Somatic Isoform; Angiotensin-Converting Enzyme;

Function

Converts angiotensin I to angiotensin II by release of the terminal His-Leu, this results in an increase of the vasoconstrictor activity of angiotensin. Also able to inactivate bradykinin, a potent vasodilator. Has also a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety.

Biological Process

Amyloid-beta metabolic process
Angiotensin maturation
Antigen processing and presentation of peptide antigen via MHC class I
Arachidonic acid secretion
Blood vessel diameter maintenance
Blood vessel remodeling
Cell proliferation in bone marrow
Heart contraction
Hematopoietic stem cell differentiation
Hormone catabolic process
Kidney development
Mononuclear cell proliferation
Negative regulation of gap junction assembly
Negative regulation of gene expression
Negative regulation of protein binding
Neutrophil mediated immunity
Peptide catabolic process
Positive regulation of peptidyl-cysteine S-nitrosylation
Positive regulation of peptidyl-tyrosine autophosphorylation
Positive regulation of protein binding
Positive regulation of protein tyrosine kinase activity
Positive regulation of systemic arterial blood pressure
Posttranscriptional regulation of gene expression
Proteolysis
Regulation of angiotensin metabolic process
Regulation of blood pressure
Regulation of hematopoietic stem cell proliferation
Regulation of renal output by angiotensin
Regulation of smooth muscle cell migration
Regulation of systemic arterial blood pressure by renin-angiotensin
Regulation of vasoconstriction
Spermatogenesis

Cellular Location

Secreted; Cell membrane; Cytoplasm. Detected in both cell membrane and cytoplasm in neurons.

Involvement in disease

A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors.
Autosomal recessive severe disorder of renal tubular development characterized by persistent fetal anuria and perinatal death, probably due to pulmonary hypoplasia from early-onset oligohydramnios (the Potter phenotype).
Pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis.
A pathological condition characterized by bleeding into one or both cerebral hemispheres including the basal ganglia and the cerebral cortex. It is often associated with hypertension and craniocerebral trauma. Intracerebral bleeding is a common cause of stroke.

Topology

Extracellular: 30-1256 aa
Helical: 1257-1277 aa
Cytoplasmic: 1278-1306 aa

PTM

Phosphorylated by CK2 on Ser-1299; which allows membrane retention.

Santos, M. C., Toson, N. S., Pimentel, M. C., Bordignon, S. A., Mendez, A. S., & Henriques, A. T. (2020). Polyphenols composition from leaves of Cuphea spp. and inhibitor potential, in vitro, of angiotensin I-converting enzyme (ACE). Journal of ethnopharmacology, 255, 112781.

Oh, J. Y., Kim, E. A., Lee, H., Kim, H. S., Lee, J. S., & Jeon, Y. J. (2019). Antihypertensive effect of surimi prepared from olive flounder (Paralichthys olivaceus) by angiotensin-I converting enzyme (ACE) inhibitory activity and characterization of ACE inhibitory peptides. Process Biochemistry, 80, 164-170.

Abachi, S., Bazinet, L., & Beaulieu, L. (2019). Antihypertensive and angiotensin-I-converting enzyme (ACE)-inhibitory peptides from fish as potential cardioprotective compounds. Marine drugs, 17(11), 613.

Bhaskar, B., Ananthanarayan, L., & Jamdar, S. (2019). Purification, identification, and characterization of novel angiotensin I-converting enzyme (ACE) inhibitory peptides from alcalase digested horse gram flour. LWT, 103, 155-161.

Deng, Z., Liu, Y., Wang, J., Wu, S., Geng, L., Sui, Z., & Zhang, Q. (2018). Antihypertensive effects of two novel angiotensin I-converting enzyme (ACE) inhibitory peptides from Gracilariopsis lemaneiformis (Rhodophyta) in spontaneously hypertensive rats (SHRs). Marine drugs, 16(9), 299.

Auwal, S. M., Zarei, M., Tan, C. P., Basri, M., & Saari, N. (2018). Enhanced physicochemical stability and efficacy of angiotensin I-converting enzyme (ACE)-inhibitory biopeptides by chitosan nanoparticles optimized using Box-Behnken design. Scientific reports, 8(1), 1-11.

Hanafi, M. A., Hashim, S. N., Chay, S. Y., Ebrahimpour, A., Zarei, M., Muhammad, K., ... & Saari, N. (2018). High angiotensin-I converting enzyme (ACE) inhibitory activity of Alcalase-digested green soybean (Glycine max) hydrolysates. Food Research International, 106, 589-597.

Liu, C., Fang, L., Min, W., Liu, J., & Li, H. (2018). Exploration of the molecular interactions between angiotensin-I-converting enzyme (ACE) and the inhibitory peptides derived from hazelnut (Corylus heterophylla Fisch.). Food chemistry, 245, 471-480.

Daskaya-Dikmen, C., Yucetepe, A., Karbancioglu-Guler, F., Daskaya, H., & Ozcelik, B. (2017). Angiotensin-I-converting enzyme (ACE)-inhibitory peptides from plants. Nutrients, 9(4), 316.

Paiva, L., Lima, E., Neto, A. I., & Baptista, J. (2017). Angiotensin I-converting enzyme (ACE) inhibitory activity, antioxidant properties, phenolic content and amino acid profiles of Fucus spiralis L. protein hydrolysate fractions. Marine drugs, 15(10), 311.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-ACE Recombinant Antibody (V2-179257)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Mouse Anti-ACE Recombinant Antibody (V2-610921) (CAT#: CBMAB-A0064-LY)

Mouse Anti-ACE Recombinant Antibody (V2-179254) (CAT#: CBMAB-A0526-YC)

Mouse Anti-ACE Recombinant Antibody (V2-179265) (CAT#: CBMAB-A0537-YC)

Mouse Anti-ACE Recombinant Antibody (V2-631895) (CAT#: CBMAB-CA081LY)

Rat Anti-ACE Recombinant Antibody (V2-179253) (CAT#: CBMAB-A0525-YC)

Mouse Anti-ACE Recombinant Antibody (V2-179261) (CAT#: CBMAB-A0533-YC)

Mouse Anti-ACE Recombinant Antibody (V2-179262) (CAT#: CBMAB-A0534-YC)

Human Anti-ACE Recombinant Antibody (V2-360254) (CAT#: CBMAB-C1989-CQ)

Mouse Anti-ACE Recombinant Antibody (V2-179258) (CAT#: CBMAB-A0530-YC)

Mouse Anti-ACE Recombinant Antibody (V2-179250) (CAT#: CBMAB-A0522-YC)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry